Clinical and MRI remission in axial spondyloarthritis: one-year outcomes and predictors from the TRACE treat-to-target study with secukinumab.

IF 4.6 2区医学 Q1 Medicine

Arthritis Research & Therapy Pub Date : 2026-04-25 DOI:10.1186/s13075-026-03816-8

Nora Vladimirova, Mikkel Østergaard, Stylianos Georgiadis, Sengül Seven, Jakob M Møller, Bente Jensen, Rene Østgård, Rene Poggenborg, Ole Rintek Madsen, Oliver Hendricks, Lau Brix, Susanne Juhl Pedersen

引用次数: 0

查看原文本刊更多论文

轴型脊柱炎的临床和MRI缓解：使用secukinumab的TRACE治疗-靶向研究的一年结果和预测因素

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

Arthritis Research & Therapy RHEUMATOLOGY-

CiteScore

8.60

自引率

2.00%

发文量

261

审稿时长

14 weeks

期刊介绍： Established in 1999, Arthritis Research and Therapy is an international, open access, peer-reviewed journal, publishing original articles in the area of musculoskeletal research and therapy as well as, reviews, commentaries and reports. A major focus of the journal is on the immunologic processes leading to inflammation, damage and repair as they relate to autoimmune rheumatic and musculoskeletal conditions, and which inform the translation of this knowledge into advances in clinical care. Original basic, translational and clinical research is considered for publication along with results of early and late phase therapeutic trials, especially as they pertain to the underpinning science that informs clinical observations in interventional studies.